EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities

Laila N Khorasani, Asal Bastani iD, Tammy Shen iD, Gurlovellen Kaur iD, Nilpa D Shah iD, Lucia Juarez, Michelle Heyman, Julie Grassian iD, An-Chuen Cho, Emily Hotez

Vaccines · 25.04.2023 · 11 (5) · 895

DOI: 10.3390/vaccines11050895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 25.04.2023. Verfasst von Laila N Khorasani und 9 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association of University Centers on Disabilities, Centers for Disease Control, Regional Hub Mini-Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccine hesitancy is a major barrier to vaccination, hindering the success of vaccine efforts and thereby increasing public health risk to viral diseases, including COVID-19. Neurodivergent (ND) individuals, including individuals with an intellectual and/or developmental disability, have demonstrated a heightened risk of hospitalization and death due to COVID-19, highlighting the need for further research specifically on ND communities. We conducted a qualitative analysis using in-depth interviews with medical professionals, non-medical health professionals and communicators, and ND individuals or their caregivers. Using a thematic coding analysis methodology, trained coders identified major themes according to 24 distinct codes spanning across the categories of (1) barriers to vaccination; (2) facilitators to vaccination; and (3) suggestions for improving vaccine confidence. Qualitative findings identify misinformation, perception of vaccine risk, sensory sensitivities, and structural hardship as the most significant barriers to COVID-19 vaccination. We highlight the importance of accommodations to vaccination for the ND community alongside coordinated efforts by healthcare leaders to direct their communities to accurate sources of medical information. This work will inform the direction of future research on vaccine hesitancy, and the development of programs specific to the ND community’s access to vaccines.

Schlagwörter

Stichwörter der Autor:innen

COVID-19intellectual and developmental disabilityneurodivergentthematic codingvaccine hesitancy

Autor:innen und Institutionen

  • David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
  • Graduate School of Education, University of California, Riverside, CA 92521, USA.

ORCID-Profile: Asal Bastani, Tammy Shen, Gurlovellen Kaur, Nilpa D Shah, Julie Grassian

Förderung

  • Association of University Centers on Disabilities
  • Centers for Disease Control, Regional Hub Mini-Grant

Zitieren

APA

Khorasani, L. N., Bastani, A., Shen, T., Kaur, G., Shah, N. D., Juarez, L., Heyman, M., Grassian, J., Cho, A. C., & Hotez, E. (2023). A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines, 11(5), 895. https://doi.org/10.3390/vaccines11050895

Vancouver

Khorasani LN, Bastani A, Shen T, Kaur G, Shah ND, Juarez L, et al. A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines. 2023;11(5):895. doi:10.3390/vaccines11050895

BibTeX
@article{Khorasani2023,
  author = {Khorasani, Laila N and Bastani, Asal and Shen, Tammy and Kaur, Gurlovellen and Shah, Nilpa D and Juarez, Lucia and Heyman, Michelle and Grassian, Julie and Cho, An-Chuen and Hotez, Emily},
  title = {A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {5},
  pages = {895},
  doi = {10.3390/vaccines11050895}
}
Kostenlos starten →